It was reported that obesity reduces sensitivity to FGF21, resulting in increased levels of circulating FGF21 at rest, which is considered a state of FGF21 resistance [39]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.